Sevelamer - Wikipedia
https://en.m.wikipedia.org/wiki/Sevelamer
Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate). Formula: [(C₃H₇N)a+b.(C₉H₁₇N₂O)c]ₘ, where a+b:c = 9:1 Pregnancy category: AU: B3 Trade names: Renagel, Renvela
Formula: [(C₃H₇N)a+b.(C₉H₁₇N₂O)c]ₘ, where a+b:c = 9:1
Pregnancy category: AU: B3
Trade names: Renagel, Renvela
DA: 54 PA: 74 MOZ Rank: 47